Condition
Complicated Pleural Effusion/ Empyema
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Recruiting2
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07095361Phase 4Recruiting
Once Daily Intrapleural Enzyme Therapy in Complicated Parapneumonic Effusion or Empyema
NCT06734481Not ApplicableRecruitingPrimary
Effectiveness and Safety of Sodium Bicarbonate Pleural Lavage in the Treatment of Complex Pleural Effusion
NCT03716375Not ApplicableUnknownPrimary
Efficacy of Fibrinolytic Agents in Complicated Pleural Effusion
Showing all 3 trials